II Simpósio Internacional de Microbiologia Clínica
Resumo:MH-063


Poster (Painel)
MH-063Molecular Typing of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Different Public Hospitals in Recife, Pernambuco
Autores:Felipe Lira de Sá Cavalcanti (UFPE - Depto. de Genética - Universidade Federal de PernambucoUPE - ICB - Universidade de PernambucoCPQAM/FIOCRUZ - Centro de Pesquisas Aggeu Magalhães - Fiocruz) ; Anna Carolina Soares Almeida (UFPE - Depto. de Genética - Universidade Federal de PernambucoUPE - ICB - Universidade de Pernambuco) ; Marinalda Anselmo Vilela (UPE - ICB - Universidade de Pernambuco) ; Márcia Maria Camargo de Morais (UPE - ICB - Universidade de Pernambuco) ; Tereza Cristina Leal Balbino (CPQAM/FIOCRUZ - Centro de Pesquisas Aggeu Magalhães - FiocruzUFPE - Depto. de Genética - Universidade Federal de Pernambuco)

Resumo

Pseudomonas aeruginosa is a well-known nosocomial pathogen, responsible for a wide range of severe infections and able to become resistant to virtually all the antibiotics commercially available. Production of â-lactamases, such as class B metallo-beta-lactamases (MBLs) by P. aeruginosa isolates is a substantial concern to the antimicrobial therapy in hospitalized patients. The aim of this work was to detect MBL production in P. aeruginosa strains, to investigate the occurrence of blaSPM and blaIMP genes, to determine their susceptibility profiles and to analyze the isolates clonality. Were analyzed 20 samples from 2007 to 2009, obtained from three public hospitals. Antimicrobial susceptibility was performed according CLSI, 2010. The identification of MBL-producing isolates followed the method proposed by Arakawa et al. The detection of genes blaSPM-1 and blaIMP was performed by specific PCR. Molecular typing was carried out by PFGE and the clonal relation among the isolates was established in accordance with the criteria of Tenover. The results showed that only 20% (4/20) of the isolates were confirmed as MBL positives by phenotypic testing, despite the observed carbapenem resistance in most of them. The blaSPM-1 gene was only found in these isolates (4/4). None of the tested samples had blaIMP gene. Susceptibility results showed that 90% (18/20) of the isolates were fully resistant to imipenem and ceftazidime; 95% (19/20) to gentamicin and ciprofloxacin; 85% (17/20) to amikacin; 70% (14/20) to piperacilin/tazobactam and 85% (17/20) to aztreonam. All the isolates were susceptible to polimixin B. Macrorestriction patterns revealed the presence of a main clone (A) with two closely related subtypes (A1 and A2) between the four MBL positive isolates. By contrast, MBL negative were distinctly different, showing about ten non-related clones. These findings suggest that the production of MBL in the hospitals analyzed was mediated by a single epidemic clone, probably the widespread Brazilian clone. Moreover, an important finding was the high frequency of non-related and pan-resistant P. aeruginosa strains, which seems to be replacing the SPM clone in the hospitals studied.

 

Financial support: CNPq, CAPES, FIOCRUZ

 


Palavras-chave:  PFGE, metallo-beta-lactamase, Pseudomonas aeruginosa